CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dec. 8, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced […]
Read more